Pfizer Limited (PFIZER.NS)

INR 5007.55

(-0.83%)

Long Term Debt Summary of Pfizer Limited

Pfizer Limited's latest annual long term debt in 2023 was 543.5 Million INR , down -41.76% from previous year.
Pfizer Limited's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
Pfizer Limited reported annual long term debt of 933.2 Million INR in 2022, down -26.95% from previous year.
Pfizer Limited reported annual long term debt of 1.27 Billion INR in 2021, up 199.3% from previous year.
Pfizer Limited reported quarterly long term debt of - INR for 2024 Q2, down 0.0% from previous quarter.
Pfizer Limited reported quarterly long term debt of 543.5 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Pfizer Limited (2023 - 2004)

Historical Annual Long Term Debt of Pfizer Limited (2023 - 2004)

Year	Long Term Debt	Long Term Debt Growth
2023	543.5 Million INR	-41.76%
2022	933.2 Million INR	-26.95%
2021	1.27 Billion INR	199.3%
2020	426.8 Million INR	-51.87%
2019	886.8 Million INR	0.0%
2018	- INR	0.0%
2017	- INR	-100.0%
2016	25.02 Million INR	0.0%
2015	25.02 Million INR	0.0%
2014	25.02 Million INR	0.0%
2013	- INR	0.0%
2012	- INR	0.0%
2011	- INR	0.0%
2010	- INR	0.0%
2009	- INR	0.0%
2008	- INR	0.0%
2007	- INR	0.0%
2006	- INR	0.0%
2005	- INR	-100.0%
2004	120 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- INR	0.0%
2024 Q2	- INR	0.0%
2023 Q4	543.5 Million INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	543.5 Million INR	-41.76%
2023 Q3	- INR	-100.0%
2023 Q2	733.5 Million INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	1.11 Billion INR	0.0%
2022 FY	933.2 Million INR	-26.95%
2022 Q4	933.2 Million INR	0.0%
2021 Q2	533.1 Million INR	0.0%
2021 FY	1.27 Billion INR	199.3%
2021 Q3	- INR	-100.0%
2021 Q4	1.27 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2020 FY	426.8 Million INR	-51.87%
2020 Q4	426.8 Million INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q2	903.3 Million INR	0.0%
2019 FY	886.8 Million INR	0.0%
2019 Q3	- INR	0.0%
2019 Q4	886.8 Million INR	0.0%
2019 Q2	- INR	0.0%
2019 Q1	- INR	0.0%
2018 FY	- INR	0.0%
2018 Q4	- INR	0.0%
2018 Q3	- INR	0.0%
2018 Q2	- INR	0.0%
2018 Q1	- INR	0.0%
2017 Q1	- INR	-100.0%
2017 Q2	25 Million INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	- INR	0.0%
2017 FY	- INR	-100.0%
2016 Q1	- INR	-100.0%
2016 FY	25.02 Million INR	0.0%
2016 Q4	25.02 Million INR	0.0%
2016 Q3	- INR	-100.0%
2016 Q2	25 Million INR	0.0%
2015 Q3	- INR	-100.0%
2015 Q1	- INR	-100.0%
2015 Q4	25.02 Million INR	0.0%
2015 FY	25.02 Million INR	0.0%
2015 Q2	25 Million INR	0.0%
2014 Q3	- INR	0.0%
2014 FY	25.02 Million INR	0.0%
2014 Q2	- INR	0.0%
2014 Q1	- INR	0.0%
2014 Q4	25.02 Million INR	0.0%
2013 Q2	- INR	0.0%
2013 Q4	- INR	0.0%
2013 FY	- INR	0.0%
2013 Q3	- INR	0.0%
2013 Q1	- INR	0.0%
2012 FY	- INR	0.0%
2012 Q4	- INR	0.0%
2012 Q3	- INR	0.0%
2011 FY	- INR	0.0%
2010 FY	- INR	0.0%
2009 FY	- INR	0.0%
2008 FY	- INR	0.0%
2007 FY	- INR	0.0%
2006 FY	- INR	0.0%
2005 FY	- INR	-100.0%
2004 FY	120 Million INR	0.0%

Peer Long Term Debt Comparison of Pfizer Limited

Name	Long Term Debt	Long Term Debt Difference
Abbott India Limited	367.6 Million INR	-47.851%
Cipla Limited	2.25 Billion INR	75.889%
Gland Pharma Limited	1.06 Billion INR	48.986%
GlaxoSmithKline Pharmaceuticals Limited	64.69 Million INR	-740.148%
Kopran Limited	166.02 Million INR	-227.356%
Marksans Pharma Limited	1.9 Billion INR	71.398%
NGL Fine-Chem Limited	7.44 Million INR	-7197.261%
Sanofi India Limited	139 Million INR	-291.007%
SMS Pharmaceuticals Limited	1.22 Billion INR	55.482%
TTK Healthcare Limited	7.98 Million INR	-6704.808%